This real-world cohort describes patients with mantle cell lymphoma presenting predominantly with advanced-stage, high-risk disease. Treatment approaches differed by age, with comparable overall responses across groups. The findings suggest that prognostic indices and functional status assessment may aid outcome evaluation in routine practice.
Hoz et al. (Fri,) studied this question.